Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

11/03/2015 Sustainability: the Barcelona Synchrotron Park focuses on birds and bats… 05/03/2015 Wastewater that produces green energy 26/02/2015 ALBA, CSIC and Alibava develop an X-Ray detector 20/02/2015 The pressure that makes conductivity higher: new record in the ICN2 11/02/2015 Presentation of the Big Data CoE Barcelona initiative 06/02/2015 Come investigate at the ALBA synchrotron: 2015 new call for proposals
34 35 36 37 38 39 40 41 42 43 44